Diffuse Idiopathic Skeletal Hyperostosis — DISH — is one of those conditions that tends to arrive quietly. Most people first hear the name when a radiologist mentions "flowing calcifications" on a spine X-ray taken for something else entirely.

Inclusion body myositis has a way of being misread for years. The grip that quietly loosens, the stairs that become a calculation, the swallowing that starts to require concentration — these are not vague symptoms, but they belong to a disease that remains underdiagnosed, often confused with polymyositis or simply with aging.

Living with spinal muscular atrophy — or caring for someone who does — means navigating a disease where the stakes are high, the science moves fast, and the gap between what specialists know and what gets communicated in a standard appointment can be significant.

If you have pes cavus — a foot with an unusually high arch — you have probably been told to get custom orthotics, stretch your calves, and strengthen your intrinsic foot muscles. That advice is not wrong, but for a significant proportion of people with high-arched feet, it leaves out the most important question: why does your arch look the way it does?

Niemann-Pick disease is not a single condition. It is a group of inherited lysosomal storage disorders defined by a molecular failure in how the body processes specific fats — primarily sphingomyelin and cholesterol — at the cellular level.

Living with Farber disease — or caring for someone who has it — means navigating a condition that most physicians have read about once, if at all. The classic clinical triad of painful swollen joints, subcutaneous nodules, and a hoarse or weak cry in infancy can spend years being misdiagnosed as juvenile arthritis or an unclassified connective tissue disorder.

Pemphigus vulgaris is one of the more disorienting autoimmune diagnoses to receive. The blisters appear on skin and mucous membranes, treatment is aggressive, and the disease can feel entirely beyond your control.

Living with spinocerebellar ataxia places you in a frustrating paradox. The genetic cause is often precisely known — a specific gene, a specific repeat count, sometimes the exact size of the expansion — yet the clinical conversation frequently ends at "degenerative condition, supportive care only." That gap between molecular precision and practical guidance is real, and this article is an attempt…

If your family has just received a Freeman-Sheldon syndrome diagnosis, or you're a clinician trying to build a coherent monitoring plan for a patient with this rare condition, you've probably noticed that most of what's written online falls into one of two buckets: dense genetics papers that don't translate into a plan, or generic "rare disease" pages that don't go deep enough to be useful day to…

Getting a diagnosis that includes the words "central core disease" often raises more questions than it answers. A muscle biopsy shows cores. A weakness pattern fits. But the label itself does not tell you which gene is responsible, what the practical risks are day to day, or what — if anything — can be done about it.

If you are reading this, there is a good chance you already know that Kennedy disease — also called spinal and bulbar muscular atrophy, or SBMA — is not something you can simply push through with willpower.